Drug Shortage Report for MYLAN-ELETRIPTAN
Report ID | 121654 |
Drug Identification Number | 02342243 |
Brand name | GD-ELETRIPTAN |
Common or Proper name | GD-ELETRIPTAN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ELETRIPTAN |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-08-17 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-09-21 |
Shortage status | Resolved |
Updated date | 2020-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-09-22 | English | Compare |
v9 | 2020-09-21 | French | Compare |
v8 | 2020-09-21 | English | Compare |
v7 | 2020-09-08 | French | Compare |
v6 | 2020-09-08 | English | Compare |
v5 | 2020-08-18 | English | Compare |
v4 | 2020-08-07 | French | Compare |
v3 | 2020-08-07 | English | Compare |
v2 | 2020-08-04 | French | Compare |
v1 | 2020-08-04 | English | Compare |
Showing 1 to 10 of 10